Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Arkh Patol ; 66(5): 45-9, 2004.
Article in Russian | MEDLINE | ID: mdl-15575388

ABSTRACT

Extraovarian malignant Brenner tumour in a female of 35. Rapid infiltrating growth with the destruction of tumour. All extraovarian tumours described so far were benign, located in the mesosalpinx, uterus or vagina. In this case the starting point of the tumour was in the vagina wall or in the recto-vaginal septum. Histological picture produced difficulties in establishing histogenesis of malignancy. The true nature of the tumour was established only immunohistochemically.


Subject(s)
Brenner Tumor/pathology , Pelvic Neoplasms/pathology , Adult , Female , Humans , Ovary
2.
J Clin Oncol ; 11(5): 937-42, 1993 May.
Article in English | MEDLINE | ID: mdl-8387578

ABSTRACT

PURPOSE: A study was undertaken to improve our understanding of the clinicopathologic features and therapeutic outcome for adults with primary Ki-1 anaplastic large-cell lymphoma (ALCL). PATIENTS AND METHODS: A retrospective review of records of 31 adult patients with primary Ki-1 ALCL was performed. The analysis included stage and distribution of disease, tumor-cell phenotype, response to initial and salvage therapy, and disease-free and overall survival. RESULTS: The median age of patients was 44 years (range, 16 to 86). Forty-eight percent of patients tested had lymphomas of T-cell phenotype, 30% lymphomas of B-cell phenotype, and 22% of non-T-, non-B-cell phenotype. Twenty-nine percent of patients had stages I and II disease, 65% demonstrated extranodal involvement, and 32% had skin involvement at presentation. Most patients received intensive chemotherapy and 48% achieved a sustained complete remission (CR), with an additional 17% of patients treated successfully with salvage therapy. Stage was highly predictive of achieving a sustained CR, but bulk disease and B symptoms did not predict for relapse after initial therapy or survival. Of seven patients who underwent autologous bone marrow transplantation (ABMT), three remain disease-free 9 to 42 months after transplant. CONCLUSION: Patients with Ki-1 ALCL have a high frequency of advanced-stage disease and extranodal involvement and are more likely to have tumors of T-cell phenotype than patients with large-cell lymphoma. However, response to standard lymphoma chemotherapy is similar to other patients with large-cell lymphoma, with a high remission rate in early-stage disease. Patients with advanced-stage disease have a poor remission duration and may require more intensive therapy, as may also be the case with large-cell lymphoma.


Subject(s)
Antigens, CD/analysis , Antigens, Neoplasm/analysis , Lymphoma, Large B-Cell, Diffuse/drug therapy , Lymphoma, Large B-Cell, Diffuse/immunology , Adolescent , Adult , Aged , Aged, 80 and over , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Female , Follow-Up Studies , Humans , Ki-1 Antigen , Lymphoma, Large B-Cell, Diffuse/pathology , Male , Middle Aged , Neoplasm Staging , Outcome Assessment, Health Care , Phenotype , Retrospective Studies , Salvage Therapy
3.
Hum Pathol ; 22(1): 94-6, 1991 Jan.
Article in English | MEDLINE | ID: mdl-1985085

ABSTRACT

A mediastinal ependymoma in a 35-year-old Caucasian woman is reported. The tumor was located in a paravertebral posterior mediastinal location. No continuity with the spinal canal or with the lung was identified. The diagnosis was confirmed by immunoperoxidase staining for glial fibrillary protein and by the presence of cilia within intracytoplasmic vacuoles. To the best of our knowledge, this is the second reported case of ependymoma in this location.


Subject(s)
Ependymoma/pathology , Mediastinal Neoplasms/pathology , Adult , Ependymoma/diagnosis , Female , Humans , Mediastinal Neoplasms/diagnosis
4.
Curr Med Res Opin ; 8 Suppl 3: 25-37, 1983.
Article in English | MEDLINE | ID: mdl-6617239

ABSTRACT

Indapamide, a newly developed antihypertensive agent with modest diuretic properties, reduced mean arterial pressure toward normal in dogs made hypertensive with salt and DOCA, while low-dose furosemide (0.1 mg per day) and hydrochlorothiazide (1 and 50 mg per day) did not result in similar degrees of blood pressure control. Indapamide, low-dose furosemide and hydrochlorothiazide treatment all resulted in similar decreases in body weight suggesting that the antihypertensive effect of indapamide occurs through a mechanism independent of contraction of extracellular fluid volume. Intravenous indapamide at doses of 0.3, 1.0 and 3.0 mg/kg caused progressive increases in sodium, potassium and chloride excretion when urine losses were replaced by isotonic saline to prevent extracellular fluid volume contraction. Only at 3.0 mg/kg did plasma potassium decrease significantly (2.92 +/- 0.03 to 2.69 +/- 0.05 mmol/l; p less than 0.05). Neither glomerular filtration rate (GFR) nor renal blood flow (flowmeter) decreased in a dose-related manner; however, effective renal plasma flow assessed by para-aminohippurate clearance did decrease about 15% at the highest dose (p less than 0.05). Proximal re-collection micropuncture studies demonstrated decreased proximal reabsorption. Cortical diluting segment reabsorption was decreased, but CNa + CH2O/GFR increased from 7% to 11% (p less than 0.05). These results indicate that, at doses up to 3.0 mg/kg, indapamide causes a natriuresis which is modest and similar to that seen with thiazides. No decrease in GFR or renal blood flow was observed. This drug apparently exerts a natriuretic effect through an inhibition of solute reabsorption in both the proximal nephron and the cortical diluting segment.


Subject(s)
Diuretics/administration & dosage , Electrolytes/metabolism , Hypertension/physiopathology , Indapamide/administration & dosage , Kidney Tubules, Proximal/metabolism , Kidney/physiopathology , Animals , Blood Pressure/drug effects , Chlorides/metabolism , Dogs , Dose-Response Relationship, Drug , Female , Furosemide/administration & dosage , Glomerular Filtration Rate/drug effects , Hemodynamics/drug effects , Hydrochlorothiazide/administration & dosage , Potassium/metabolism , Renal Circulation/drug effects , Sodium/metabolism
9.
Arch Surg ; 102(3): 172-4, 1971 Mar.
Article in English | MEDLINE | ID: mdl-4993462
10.
Arch Surg ; 100(6): 741-2, 1970 Jun.
Article in English | MEDLINE | ID: mdl-5444498
SELECTION OF CITATIONS
SEARCH DETAIL
...